A simple design that eases use can overcome challenges faced when changing established medical procedures, said a winner of the 2018 Medical Design Excellence Awards.
News & Features
Abbott Laboratories presented some disappointing data for its bioresorbable stent program at TCT, but it was a different story for Reva Medical's scaffold.
ConvaTec's shares plunged Monday after the advanced wound care leader drastically lowered its revenue expectations and announced the sudden departure of CEO Paul Moraviec.
Zimmer will partner with Apple to study the mymobility app’s impact on patient outcomes and overall costs for joint replacement patients.
The Redmond, WA-based company will partner with Genoox, which has developed a comprehensive cloud-based advanced framework for Next Generation DNA Sequencing.
Rapid testing results could encourage more-appropriate use of antibiotics, and this flu season could put that theory to work.
Medical device executives are most likely on the edge of their seats with the upcoming elections. Not only is a permanent repeal of the medical device excise tax on their minds, but action on other healthcare issues could impact their business.
A report posted in FDA's MedSun database describes two heart pumps that were returned to the manufacturer for investigation.
Medtronic has issued a software update to address cybersecurity vulnerabilities associated with the Internet connection between two models of CareLink programmers used to download software from the company's network.
The San Diego-based company is looking at a potential sale or merger and has reduced its board and cut its workforce by 80%.
The Nashua, NH-based company plans to showcase the technology at The European Society of Breast Imaging annual meeting being held this weekend and at RSNA.
An expert lays out how the medtech industry can adapt to Virtual and Augmented Reality changing the healthcare landscape.
The Pacific Research Institute released a new study that points to five core tax principles and how the 2.3% medical device tax violates each.
The Minneapolis-based company is developing a low-energy implantable defibrillation therapy designed to more gently restore normal heart rhythm.